Therapeutic strategy for the patients with coexisting gastroesophageal reflux disease and postprandial distress syndrome of functional dyspepsia.
Kimio IsshiHiroto FuruhashiKoji NakadaPublished in: JGH open : an open access journal of gastroenterology and hepatology (2020)
The results of this retrospective study suggest no benefit of PPI-prokinetic combination versus PPI monotherapy in adult patients with FD-GERD overlap; therefore, PPI monotherapy could be an adequate initial treatment for such patients.
Keyphrases
- gastroesophageal reflux disease
- end stage renal disease
- combination therapy
- protein protein
- ejection fraction
- newly diagnosed
- open label
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- type diabetes
- clinical trial
- randomized controlled trial
- small molecule
- patient reported outcomes
- helicobacter pylori infection
- metabolic syndrome
- helicobacter pylori
- insulin resistance
- irritable bowel syndrome